{"id":"TestMELD_3_0.v7","gdl_version":"2.0","concept":"gt0001","language":{"original_language":"ISO_639-1::en"},"description":{"original_author":{"name":"Umiah ","email":"umiah.gohar@gmail.com"},"lifecycle_state":"Not set","details":{"en":{"id":"en","keywords":[],"use":"The primary audience for this document is adult liver transplant programs preparing for implementation of MELD 3.0.  \n\nMELD 3.0 improves the accuracy of the MELD calculation by: \n\n• Incorporating additional variables (albumin and sex) \n\n• Updating coefficients for existing variables \n\n• Introducing interaction terms \n\n• Lowering the maximum creatinine value from 4.0 to 3.0 mg/dL.  \n\nMELD 3.0 will apply to all adult liver transplant candidates (registered after turning 18) and to adolescent candidates (age 12-17).  ","purpose":"MELD is the standard used by the Organ Procurement and Transplantation Network (OPTN) and determines who is the highest priority to receive liver transplants in the US. Predicts estimated 90-day survival. ","misuse":"Values should be no more than 48 hours old.\n\nADVICE\n\n•Consider referral to hepatologist or liver transplant center for patients with MELD Score ≥10.\n\n•MELD Score should be periodically re-assessed, as it changes with changing lab values.\n\n•All cirrhosis patients should be periodically screened for hepatocellular carcinoma with serum alpha-fetoprotein (AFP) and by appropriate imaging to see if they can earn “standard MELD exceptions”.\n\nCRITICAL ACTIONS\n\nStandard MELD Exceptions\n\nThe following conditions are automatically assigned a MELD Score of 22 (28 in case of hyperoxaluria), with a 10% increase in score every 3 months from diagnosis.\n\n• Hepatocellular carcinoma (HCC) with one lesion between 2 - 5 cm or two to three lesions &lt;3 cm (Milan criteria), provided no vascular invasion or extrahepatic disease.\n\n• Hepatopulmonary syndrome with PaO2 &lt;60 mmHg on room air.\n\n• Portopulmonary hypertension, with mean pulmonary artery pressure (mPAP) &gt;25 mmHg at rest but maintained &lt;35 mmHg with treatment.\n\n• Hepatic artery thrombosis 7–14 days post-liver transplantation.\n\n• Familial amyloid polyneuropathy, as diagnosed by identification of the transthyretin (TTR) gene mutation by DNA analysis or mass spectrometry in a biopsy sample and confirmation of amyloid deposition in an involved organ.\n\n• Primary hyperoxaluria with evidence of alanine glyoxylate aminotransferase deficiency (these patients requires combined liver-kidney transplantation).\n\n• Cystic fibrosis with FEV1 (forced expiratory volume in 1 second) &lt;40%.\n\n• Hilar cholangiocarcinoma."}},"other_details":{"references":"Trivedi, Hirsh D. MD1. The Evolution of the MELD Score and Its Implications in Liver Transplant Allocation: A Beginner's Guide for Trainees. ACG Case Reports Journal 9(5):p e00763, May 2022. | DOI: 10.14309/crj.0000000000000763 \n\nKim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, Wood NL, Gentry SE, Kwong AJ. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era. Gastroenterology. 2021;161(6):1887-1895.e4. doi:10.1053/j.gastro.2021.08.050. Available from: https://www.sciencedirect.com/science/article/pii/S0016508521034697\n\nO’Leary JG, Bajaj JS. MELD 3.0: One Small Step for Womankind or One Big Step for Everyone? Gastroenterology. 2022;162(6):1780-1781. doi:10.1053/j.gastro.2021.09.014. Available from: https://www.sciencedirect.com/science/article/pii/S0016508521034934\n\nImproving Liver Allocation: MELD 3.0 FAQ [Internet]. 2023 Jul 13 [cited 2024 May 21]. Available from: https://optn.transplant.hrsa.gov/media/fyxhlkp5/improving-liver-allocation-meld-30-faq.pdf\n\nOPTN MELD serum sodium policy changes [Internet]. 2015 Nov 11 [cited 2024 May 21]. Available from: https://optn.transplant.hrsa.gov/news/meld-serum-sodium-policy-changes/"},"other_contributors":["Anna Axell"]},"definition":{"data_bindings":{"gt0002":{"id":"gt0002","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.basic_demographic_egf.v1","template_id":"openEHR-EHR-OBSERVATION.basic_demographic_egf.v1","elements":{"gt0003":{"id":"gt0003","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0004]"},"gt0067":{"id":"gt0067","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0013]"}}},"gt0004":{"id":"gt0004","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.lab_test-liver_function.v1","template_id":"openEHR-EHR-OBSERVATION.lab_test-liver_function.v1","elements":{"gt0005":{"id":"gt0005","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0078.4]"}}},"gt0008":{"id":"gt0008","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.laboratory_test_result-serum_albumin.v0","template_id":"openEHR-EHR-OBSERVATION.laboratory_test_result-serum_albumin.v0","elements":{"gt0009":{"id":"gt0009","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0.121]"}}},"gt0010":{"id":"gt0010","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.inr.v0","template_id":"openEHR-EHR-OBSERVATION.inr.v0","elements":{"gt0011":{"id":"gt0011","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0004]"}}},"gt0012":{"id":"gt0012","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.lab_test-fractional_sodium_excretion.v1","template_id":"openEHR-EHR-OBSERVATION.lab_test-fractional_sodium_excretion.v1","elements":{"gt0013":{"id":"gt0013","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0078.5.1]"}}},"gt0014":{"id":"gt0014","type":"OUTPUT","model_id":"openEHR-EHR-OBSERVATION.basic_demographic_egf.v1","template_id":"openEHR-EHR-OBSERVATION.basic_demographic_egf.v1","elements":{"gt0015":{"id":"gt0015","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0004]"},"gt0068":{"id":"gt0068","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0013]"}}},"gt0016":{"id":"gt0016","type":"OUTPUT","model_id":"openEHR-EHR-OBSERVATION.lab_test-liver_function.v1","template_id":"openEHR-EHR-OBSERVATION.lab_test-liver_function.v1","elements":{"gt0017":{"id":"gt0017","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0078.4]"}}},"gt0018":{"id":"gt0018","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.lab_test_creatinine.v1","template_id":"openEHR-EHR-OBSERVATION.lab_test_creatinine.v1","elements":{"gt0019":{"id":"gt0019","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0005]"}}},"gt0020":{"id":"gt0020","type":"OUTPUT","model_id":"openEHR-EHR-OBSERVATION.lab_test_creatinine.v1","template_id":"openEHR-EHR-OBSERVATION.lab_test_creatinine.v1","elements":{"gt0021":{"id":"gt0021","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0005]"}}},"gt0022":{"id":"gt0022","type":"OUTPUT","model_id":"openEHR-EHR-OBSERVATION.laboratory_test_result-serum_albumin.v0","template_id":"openEHR-EHR-OBSERVATION.laboratory_test_result-serum_albumin.v0","elements":{"gt0023":{"id":"gt0023","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0.121]"}}},"gt0024":{"id":"gt0024","type":"OUTPUT","model_id":"openEHR-EHR-OBSERVATION.inr.v0","template_id":"openEHR-EHR-OBSERVATION.inr.v0","elements":{"gt0025":{"id":"gt0025","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0004]"}}},"gt0026":{"id":"gt0026","type":"OUTPUT","model_id":"openEHR-EHR-OBSERVATION.lab_test-fractional_sodium_excretion.v1","template_id":"openEHR-EHR-OBSERVATION.lab_test-fractional_sodium_excretion.v1","elements":{"gt0027":{"id":"gt0027","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0078.5.1]"}}},"gt0054":{"id":"gt0054","type":"OUTPUT","model_id":"openEHR-EHR-OBSERVATION.meld_score.v1","template_id":"openEHR-EHR-OBSERVATION.meld_score.v1","elements":{"gt0055":{"id":"gt0055","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0005]"}}},"gt0058":{"id":"gt0058","type":"OUTPUT","model_id":"openEHR-EHR-EVALUATION.meld_score.v1","template_id":"openEHR-EHR-EVALUATION.meld_score.v1","elements":{"gt0059":{"id":"gt0059","path":"/data[at0001]/items[at0002]"}}},"gt0071":{"id":"gt0071","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.basic_demographic_egf.v1","template_id":"openEHR-EHR-OBSERVATION.basic_demographic_egf.v1","elements":{"gt0072":{"id":"gt0072","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0004]"}}}},"rules":{"gt0049":{"id":"gt0049","priority":24,"then":["$gt0050|Boolean_gender| = 1"],"when":["$gt0003|Birth sex|.code == local::at0006|Female|"],"description":" The OPTN is updating the label for the “Gender” field to be “Birth Sex” to align with current data collection standards."},"gt0051":{"id":"gt0051","priority":23,"then":["$gt0050|Boolean_gender| = 0"],"when":["$gt0003|Birth sex|.code == local::at0005|Male|"],"description":" The OPTN is updating the label for the “Gender” field to be “Birth Sex” to align with current data collection standards."},"gt0069":{"id":"gt0069","priority":22,"then":["local::at0006|Female|"],"when":["$gt0067|Age| < 18,a || $gt0067|Age| >= 12,a"],"description":"In the current liver allocation system, adolescent candidates (age at least 12 and less than 18) are assigned a MELD score. Under this new policy, adolescent candidates will continue to utilize MELD 3.0, but both male and female adolescent candidates will receive the 1.33 points that will be provided to all adult female candidates. This is based on data that shows there is no sexbased disparity in the adolescent population. Both male and female adolescent candidates registered before turning 18 will maintain the 1.33 points if they remain on the OPTN Waiting List after turning 18.  "},"gt0070":{"id":"gt0070","priority":21,"then":[],"when":["$gt0072|Sex for Purposes of Adult MELD Calculation| == local::at0006|Female|"],"description":"To ensure that the appropriate candidates are provided the 1.33 points, there will be a new data field, “Sex for purposes of adult MELD calculation.” For the majority of transplant candidates, their sex for purposes of adult MELD calculation will be the same as their birth sex. However, there will be some candidates whose sex for purposes of adult MELD calculation is different than their sex at birth. This field is included to ensure that candidates are appropriately categorized for the purposes of the MELD 3.0 score.   "},"gt0073":{"id":"gt0073","priority":20,"then":["local::at0005|Male|"],"when":["$gt0072|Sex for Purposes of Adult MELD Calculation| == local::at0005|Male|"]},"gt0048":{"id":"gt0048","priority":19,"then":["$gt0023|Serum Albumin| = 3.5,gm/dl"],"when":["$gt0023|Serum Albumin| > 3.5,gm/dl"],"description":""},"gt0047":{"id":"gt0047","priority":18,"then":["$gt0023|Serum Albumin| = 1.5,gm/dl"],"when":["$gt0023|Serum Albumin| < 1.5,gm/dl"],"description":""},"gt0046":{"id":"gt0046","priority":17,"then":["$gt0023|Serum Albumin| = $gt0009|Serum Albumin|","$gt0009|Serum Albumin|.unit = 'gm/dl'"],"when":["$gt0072|Sex for Purposes of Adult MELD Calculation|"],"description":""},"gt0044":{"id":"gt0044","priority":16,"then":["$gt0045|Albumin conversion factor| = 10.0"],"when":["$gt0009|Serum Albumin|.unit == 'gm/l'"],"description":""},"gt0043":{"id":"gt0043","priority":15,"then":["$gt0025|INR|.magnitude = $gt0011|INR|.magnitude","$gt0025|INR|.unit = '1'"],"when":["$gt0011|INR| >= 1,1"],"description":""},"gt0042":{"id":"gt0042","priority":14,"then":["$gt0025|INR| = 1,1"],"when":["$gt0011|INR| < 1,1"],"description":""},"gt0041":{"id":"gt0041","priority":13,"then":["$gt0027|serum Sodium (sNa)|.magnitude = 137","$gt0027|serum Sodium (sNa)|.unit = 'mmol/l'"],"when":["( $gt0013|serum Sodium (sNa)| > 137,mmol/l ) || ( $gt0013|serum Sodium (sNa)| > 137,mEq/l )"],"description":""},"gt0040":{"id":"gt0040","priority":12,"then":["$gt0027|serum Sodium (sNa)|.magnitude = 125","$gt0027|serum Sodium (sNa)|.unit = 'mmol/l'"],"when":["( $gt0013|serum Sodium (sNa)| < 125,mmol/l ) || ( $gt0013|serum Sodium (sNa)| < 125,mEq/l )"],"description":""},"gt0039":{"id":"gt0039","priority":11,"then":["$gt0027|serum Sodium (sNa)| = $gt0013|serum Sodium (sNa)|","$gt0013|serum Sodium (sNa)|.unit = 'mmol/l'"],"when":["( $gt0013|serum Sodium (sNa)|.magnitude >= 125 ) || ( $gt0013|serum Sodium (sNa)|.magnitude <= 137 )"],"description":""},"gt0065":{"id":"gt0065","priority":10,"then":["$gt0038|Sodium conversion factor| = 1.0"],"when":["$gt0013|serum Sodium (sNa)|.unit == 'mmol/l'"],"description":""},"gt0036":{"id":"gt0036","priority":9,"then":["$gt0021|Serum Creatinine| = 3,mg/dl"],"when":["$gt0021|Serum Creatinine| > 3,mg/dl"],"description":""},"gt0035":{"id":"gt0035","priority":8,"then":["$gt0021|Serum Creatinine| = 1,mg/dl"],"when":["$gt0021|Serum Creatinine| < 1,mg/dl"],"description":""},"gt0034":{"id":"gt0034","priority":7,"then":["$gt0021|Serum Creatinine|.magnitude = $gt0019|Serum Creatinine|.magnitude / $gt0033|Creatinine conversion factor|","$gt0021|Serum Creatinine|.precision = 2","$gt0021|Serum Creatinine|.unit = 'mg/dl'"],"when":["$gt0019|Serum Creatinine| != null"],"description":""},"gt0032":{"id":"gt0032","priority":6,"then":["$gt0033|Creatinine conversion factor| = 88.42"],"when":["$gt0019|Serum Creatinine|.unit == 'µmol/l'"],"description":""},"gt0031":{"id":"gt0031","priority":5,"then":["$gt0017|Total bilirubin| = 1,mg/dl"],"when":["$gt0017|Total bilirubin| < 1,mg/dl"],"description":""},"gt0030":{"id":"gt0030","priority":4,"then":["$gt0017|Total bilirubin|.magnitude = $gt0005|Total bilirubin|.magnitude / $gt0029|Bilirubin conversion factor|","$gt0017|Total bilirubin|.precision = 2","$gt0017|Total bilirubin|.unit = 'mg/dl'"],"when":["$gt0005|Total bilirubin| != null"],"description":""},"gt0028":{"id":"gt0028","priority":3,"then":["$gt0029|Bilirubin conversion factor| = 17.1"],"when":["$gt0005|Total bilirubin|.unit == 'µmol/l'"],"description":""},"gt0052":{"id":"gt0052","priority":2,"then":["$gt0055|MELD score 3.0|.magnitude = 1.33 * ($gt0050|Boolean_gender|) + 4.56 * log ( $gt0017|Total bilirubin| ) + 0.82 * ( 137 - $gt0027|serum Sodium (sNa)| ) - 0.24 * log ( 137 - $gt0027|serum Sodium (sNa)| ) * log ( $gt0017|Total bilirubin| ) + 9.09 * log ( $gt0025|INR| ) + 11.14 * log ( $gt0021|Serum Creatinine| ) + 1.85 * ( 3.5 - $gt0023|Serum Albumin| ) - 1.83 * ( 3.5 - $gt0023|Serum Albumin| ) * log ( $gt0021|Serum Creatinine| ) + 6","$gt0055|MELD score 3.0|.unit = '1'","$gt0055|MELD score 3.0|.precision = '1'"],"when":["$gt0005|Total bilirubin| != null","$gt0009|Serum Albumin| != null","$gt0011|INR| != null","$gt0013|serum Sodium (sNa)| != null","$gt0019|Serum Creatinine| != null"],"description":""},"gt0066":{"id":"gt0066","priority":1,"then":["$gt0059|90-day survival|.magnitude = 0.946exp ( 0.17698 * $gt0055|MELD score 3.0| - 3.56 ) * 100"],"when":["$gt0055|MELD score 3.0| != null"],"description":"Estimated 90-day survival = 0.946exp(0.17698*MELD 3.0 – 3.56) * 100"}},"default_actions":["$gt0045|Albumin conversion factor| = 1","$gt0033|Creatinine conversion factor| = 1","$gt0029|Bilirubin conversion factor| = 1","$gt0038|Sodium conversion factor| = 1","$gt0050|Boolean_gender| = 1"],"pre_conditions":["$gt0067|Age|.magnitude >= 12"]},"ontology":{"term_definitions":{"en":{"id":"en","terms":{"gt0001":{"id":"gt0001","text":"Test MELD 3.0","description":"MELD 3.0, implemented 2023, is the current standard calculation for organ transplantation consideration in the United States.\n\nMELD 3.0 will address the sex-based disparity that has existed in liver allocation since the original MELD score was implemented. MELD 3.0 includes 1.33 points for candidates who are female. In addition, MELD 3.0 better predicts risk of waitlist mortality for all liver candidates by updating the coefficients for each of the variables in the score, adding albumin as a factor, introducing interaction terms, and lowering the maximum creatinine value from 4.0 to 3.0 mg/dL.  \n\nFor all MELD candidates (age 12 and older), transplant programs will be required to submit an albumin value when editing a candidate record, as albumin is now included in the MELD 3.0 calculation. Albumin is already required when adding an adult or adolescent liver candidate to the OPTN Waiting List.  In addition, because MELD 3.0 includes additional points for adult female candidates, there are changes to data collection related to the candidate’s sex outlined below.  "},"gt0003":{"id":"gt0003","text":"Birth sex"},"gt0005":{"id":"gt0005","text":"Total bilirubin"},"gt0009":{"id":"gt0009","text":"Serum Albumin"},"gt0011":{"id":"gt0011","text":"INR"},"gt0013":{"id":"gt0013","text":"serum Sodium (sNa)"},"gt0015":{"id":"gt0015","text":"Birth sex"},"gt0017":{"id":"gt0017","text":"Total bilirubin"},"gt0019":{"id":"gt0019","text":"Serum Creatinine"},"gt0021":{"id":"gt0021","text":"Serum Creatinine"},"gt0023":{"id":"gt0023","text":"Serum Albumin"},"gt0025":{"id":"gt0025","text":"INR"},"gt0027":{"id":"gt0027","text":"serum Sodium (sNa)"},"gt0028":{"id":"gt0028","text":"Bilirubin conversion rule","description":""},"gt0029":{"text":"Bilirubin conversion factor","id":"gt0029"},"gt0030":{"id":"gt0030","text":"Bilirubin µmol/L to mg/dL","description":""},"gt0031":{"id":"gt0031","text":"Bilirubin <1  mg/dL","description":""},"gt0032":{"id":"gt0032","text":"Creatinine conversion rule","description":""},"gt0033":{"text":"Creatinine conversion factor","id":"gt0033"},"gt0034":{"id":"gt0034","text":"Creatinine µmol to mg/dL","description":""},"gt0035":{"id":"gt0035","text":"Creatinine <1 mg/dL","description":""},"gt0036":{"id":"gt0036","text":"Creatinine >3 mg/dL","description":""},"gt0038":{"text":"Sodium conversion factor","id":"gt0038"},"gt0039":{"id":"gt0039","text":"Sodium normal range","description":""},"gt0040":{"id":"gt0040","text":"Sodium <125 ","description":""},"gt0041":{"id":"gt0041","text":"Sodium >137","description":""},"gt0042":{"id":"gt0042","text":"INR <1","description":""},"gt0043":{"id":"gt0043","text":"INR >1","description":""},"gt0044":{"id":"gt0044","text":"Albumin conversion rule","description":""},"gt0045":{"text":"Albumin conversion factor","id":"gt0045"},"gt0046":{"id":"gt0046","text":"Albumin normal range","description":""},"gt0047":{"id":"gt0047","text":"Albumin <1.5","description":""},"gt0048":{"id":"gt0048","text":"Albumin >3.5","description":""},"gt0049":{"id":"gt0049","text":"Birth sex Female","description":" The OPTN is updating the label for the “Gender” field to be “Birth Sex” to align with current data collection standards."},"gt0050":{"text":"Boolean_gender","id":"gt0050"},"gt0051":{"id":"gt0051","text":"Birth sex Male","description":" The OPTN is updating the label for the “Gender” field to be “Birth Sex” to align with current data collection standards."},"gt0052":{"id":"gt0052","text":"MELD 3.0 score","description":""},"gt0055":{"id":"gt0055","text":"MELD score 3.0"},"gt0059":{"id":"gt0059","text":"90-day survival"},"gt0065":{"id":"gt0065","text":"Sodium conversion rule","description":""},"gt0066":{"id":"gt0066","text":"90-day survival score","description":"Estimated 90-day survival = 0.946exp(0.17698*MELD 3.0 – 3.56) * 100"},"gt0067":{"id":"gt0067","text":"Age"},"gt0068":{"id":"gt0068","text":"Age"},"gt0069":{"id":"gt0069","text":"Adolescent = Female","description":"In the current liver allocation system, adolescent candidates (age at least 12 and less than 18) are assigned a MELD score. Under this new policy, adolescent candidates will continue to utilize MELD 3.0, but both male and female adolescent candidates will receive the 1.33 points that will be provided to all adult female candidates. This is based on data that shows there is no sexbased disparity in the adolescent population. Both male and female adolescent candidates registered before turning 18 will maintain the 1.33 points if they remain on the OPTN Waiting List after turning 18.  "},"gt0070":{"id":"gt0070","text":"Sex for purposes of adult MELD calculation Female","description":"To ensure that the appropriate candidates are provided the 1.33 points, there will be a new data field, “Sex for purposes of adult MELD calculation.” For the majority of transplant candidates, their sex for purposes of adult MELD calculation will be the same as their birth sex. However, there will be some candidates whose sex for purposes of adult MELD calculation is different than their sex at birth. This field is included to ensure that candidates are appropriately categorized for the purposes of the MELD 3.0 score.   "},"gt0072":{"id":"gt0072","text":"Sex for Purposes of Adult MELD Calculation"},"gt0073":{"id":"gt0073","text":"Sex for purposes of adult MELD calculation Male","description":"To ensure that the appropriate candidates are provided the 1.33 points, there will be a new data field, “Sex for purposes of adult MELD calculation.” For the majority of transplant candidates, their sex for purposes of adult MELD calculation will be the same as their birth sex. However, there will be some candidates whose sex for purposes of adult MELD calculation is different than their sex at birth. This field is included to ensure that candidates are appropriately categorized for the purposes of the MELD 3.0 score.   "}}}},"term_bindings":{"LOINC":{"id":"LOINC","bindings":{"gt0011":{"termId":"gt0011","termText":"INR","codes":["LOINC::6301-6"],"terminology":"LOINC"},"gt0025":{"termId":"gt0025","termText":"INR","codes":["LOINC::6301-6"],"terminology":"LOINC"},"gt0005":{"termId":"gt0005","termText":"Total bilirubin","codes":["LOINC::42719-5"],"terminology":"LOINC"},"gt0017":{"termId":"gt0017","termText":"Total bilirubin","codes":["LOINC::42719-5"],"terminology":"LOINC"},"gt0023":{"termId":"gt0023","termText":"Serum Albumin","codes":["LOINC::1751-7"],"terminology":"LOINC"},"gt0013":{"termId":"gt0013","termText":"serum Sodium (sNa)","codes":["LOINC::2947-0"],"terminology":"LOINC"},"gt0027":{"termId":"gt0027","termText":"serum Sodium (sNa)","codes":["LOINC::2947-0"],"terminology":"LOINC"},"gt0009":{"termId":"gt0009","termText":"Serum Albumin","codes":["LOINC::\t1751-7"],"terminology":"LOINC"},"gt0019":{"termId":"gt0019","termText":"Serum Creatinine","codes":["LOINC::38483-4"],"terminology":"LOINC"},"gt0021":{"termId":"gt0021","termText":"Serum Creatinine","codes":["LOINC::38483-4"],"terminology":"LOINC"}}}}}}